KARA ALLEN: Open Payments
NPI 1649989377 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,079 in 82 payments from 21 companies in 2025. Trend: 2023 $408 · 2024 $851 · 2025 $2,079
Food & beverage: $2,079
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $326 |
| Insmed, Inc. | 14 | $318 |
| AstraZeneca Pharmaceuticals LP | 10 | $283 |
| Regeneron Healthcare Solutions, Inc. | 7 | $171 |
| Pulmonx Corporation | 1 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $119 |
| Viatris Specialty LLC | 4 | $109 |
| Grifols USA, LLC | 3 | $86 |
| HARMONY BIOSCIENCES LLC | 3 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
Products named: DUPIXENT, Arikayce, CHARTIS CATHETER, AIRSUPRA, YUPELRI, TEZSPIRE, GLASSIA, Prolastin-C Liquid.
Industry payments across AL — which companies pay providers there.
